Nectar Lifesciences Limited
NECLIFE · NSE · ₹10 a share (close of 01 Oct 2026)
Available company data, source links and archived checks for Nectar Lifesciences Limited. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.
Revenue fell 100.0%; Net loss was ₹15.40 crore.
Quarter ended 2026-06-30 · consolidated · Company filing
Recorded quarterly figures
| Quarter | Revenue / income | YoY |
Profit | YoY | Net margin | Source |
|---|
| Jun 2026 | Revenue: ₹0 cr | -100.0% | Net profit: ₹-15 cr | — | -106191.0% | Company filing source |
| Mar 2026 | Revenue: ₹0 cr | -100.0% | Net profit: ₹-68 cr | — | — | Company filing source |
| Dec 2025 | Revenue: ₹0 cr | — | Net profit: ₹14 cr | — | — | Company filing source |
| Sep 2025 | Revenue: ₹5 cr | — | Net profit: ₹-176 cr | — | -3522.5% | Company filing source |
| Jun 2025 | Revenue: ₹281 cr | -21.9% | Net profit: ₹-63 cr | -2229.6% | -22.5% | Company filing source |
| Mar 2025 | Revenue: ₹431 cr | — | Net profit: ₹-130 cr | — | -30.2% | Company filing source |
YoY means change from the same quarter a year earlier.
— means no comparable figure is available. Older entries with incomplete source
details have not been revalidated under the current checks.
Who holds it — from the filings
SANJIV GOYAL 24.6%SANJIV (HUF) - KARTA SANJIV GOYAL 22.5%RAMAN GOYAL 4.8%RAJASTHAN GLOBAL SECURITIES PRIVATE LIMITED 3.7%NECTAR ORGANICS PRIVATE LIMITED 0.0%register as filed
2026-06-30
Filing timeline — what the company told the exchange
- Nectar Lifesciences Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company…
03 Oct 2026 · document
- Nectar Lifesciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015…
24 Sep 2026 · document
- General Updates. Please find attached herewith Revised Proceedings of 31st Annual General Meeting…
19 Sep 2026 · document
- Shareholders meeting. Nectar Lifesciences Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 18, 2026. Fur…
18 Sep 2026 · document
- Shareholders meeting. Nectar Lifesciences Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 18, 2026…
18 Sep 2026 · document
- General Updates. Please find attached herewith letter sent to the members pursuant to Regulation 36(1)(b)of the SEBI (LODR) Regulations, 2015.…
22 Aug 2026 · document
- Copy of Newspaper Publication. Please find attached herewith newspaper publication of notice of 31st Annual General Meeting, e-voting, book closure & other info…
21 Aug 2026 · document
- Shareholders meeting. Nectar Lifesciences Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 18, 2026…
20 Aug 2026 · document
Follow this company without reading every document yourself.
Keep its available filings, dated fact checks and disclosure alerts together.
Your saved country sets your market and its research schedule.
Start free — first week on us →
India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment
advice · cancel any time